BPC-157 and TB-500: why experimenting on yourself is not a safe recovery strategy

Short answer

For experimental recovery peptides such as BPC-157 and TB-500, there is not enough solid human evidence to recommend self-use as a safe, proven injury treatment. Uncertainty about safety is not reassurance.

Peptide is not a quality mark

Peptides are a broad group of substances. Some are used as medicines; that proves nothing about a 'research peptide' sold online. What matters is the specific substance, its use, its quality and the available research, not just the word peptide.

What is missing?

Results from cells or animals do not show that a treatment works in humans. For use in sports injuries, convincing clinical data on effectiveness, side effects and long-term use are needed. A recovery story on social media cannot replace that information.

For BPC-157, the FDA mentions possible immune reactions, impurities and limited safety data, among other things. For the thymosin beta-4 fragment referred to as TB-500, it also reports concerns and a lack of human exposure data. ^[1]

What is a sensible next step?

Have a persistent injury assessed and be honest with your doctor about any substances you have used. A 'research use only' label or a seller's report does not prove clinical safety. This article does not advise any dosage, injection schedule or alternative experimental substance.